BHV-1400

DRUG2 trials

Sponsors

Biohaven Therapeutics Ltd.

Conditions

IgA Nephropathy

Phase 1

Study of BHV-1400 in IgA Nephropathy

RecruitingNCT07054684

Biohaven Therapeutics Ltd.IgA Nephropathy

Start: 2025-07-30End: 2027-07-01Target: 20Updated: 2026-06-23

Phase 3

A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

Not yet recruitingNCT07642050

Biohaven Therapeutics Ltd.IgA Nephropathy

Start: 2026-06-01End: 2029-10-01Target: 420Updated: 2026-06-11